Sovaldi-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice
Status:
Completed
Trial end date:
2018-06-20
Target enrollment:
Participant gender:
Summary
This study will collect and evaluate information on the safety and efficacy of Sovaldi-based
regimens in routine clinical practice in Mexico. The primary objective of this study is to
assess the rates of serious adverse events/reactions (SAEs/SADRs) and adverse
events/reactions (AEs/ADRs) in adult participants with chronic hepatitis C virus (HCV)
infection treated with Sovaldi in routine clinical practice.